69 results
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
16 Apr 24
Report of Foreign Private Issuer
5:27pm
. Nature. 2007;445:866 – 873. 5 Griffiths C and Barker J. Lancet. 2007;370:263 – 271. 6 Schön M and Boehncke WH.N Engl J Med. 2005;352:1899 – 1912. 7 … F et al. N Engl J Med. 2009;361:496 – 509. 4 Lowes MA et al. Nature. 2007;445:866 – 873. 5 Griffiths C and Barker J. Lancet. 2007;370:263 – 271. 6
D
SCNI
Scinai Immunotherapeutics Ltd
12 Jan 24
$1.69 mm in equity / options / securities to be acquired, sold $1.69 mm, 4 investors
7:32am
instances or due to the nature of the offering that is the subject of this Form D, States cannot
routinely require offering materials under
F-1
EX-3.1
SCNI
Scinai Immunotherapeutics Ltd
30 Oct 23
Registration statement (foreign)
4:59pm
; the Board of Directors will determine the aforementioned minimum number based, inter alia, on the Company’s nature, size, scope of the Company’s activity
D
SCNI
Scinai Immunotherapeutics Ltd
3 Oct 23
$1.33 mm in equity / options / securities to be acquired, sold $1.33 mm, 1 investor
12:38pm
, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot
routinely require offering materials
6-K
EX-1.1
SCNI
Scinai Immunotherapeutics Ltd
19 Sep 23
Report of Foreign Private Issuer
3:06pm
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification … or such enforcement or setoff had not occurred.
5.17 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any
424B3
nml21hz5l43vs2r szwx
7 Sep 23
Prospectus supplement
5:27pm
6-K
EX-99.1
6ay3wzu ey2q
12 Jul 23
Report of Foreign Private Issuer
12:00am
10-Q
45pdva
15 May 23
Quarterly report
4:49pm
10-K
EX-14.1
6s6gnk zs5eon1bbp9
17 Apr 23
Annual report
4:06pm
10-K
EX-3.1
pfs0w8rtaz v8oitukj
17 Apr 23
Annual report
4:06pm
10-K
a8ieei
17 Apr 23
Annual report
4:06pm
6-K
EX-1.1
b9fcadrj1it05 ux6
20 Dec 22
BiondVax Announces Closing of $8 Million Underwritten Public Offering
5:29pm
424B4
11sjnw
20 Dec 22
Prospectus supplement with pricing info
11:59am
F-1/A
EX-3.1
z0dk pjwh
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
F-1/A
EX-1.1
daotiqmywmbgqf
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
F-1/A
0lfabiyy0
12 Dec 22
Registration statement (foreign) (amended)
5:25pm
424B3
bib2xc
16 Nov 22
Prospectus supplement
12:01pm
F-1
9qr6jtp fc2py
29 Sep 22
Registration statement (foreign)
9:22am
6-K
EX-99.1
m9c152m zw2gqc
12 Apr 22
Report of Foreign Private Issuer
4:15pm